Methods and compositions for T-cell coculture potency assays and use with cell therapy products
US-12570961-B2 · Mar 10, 2026 · US
Iovance Biotherapeutics Inc holds 297 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 297 |
| Recent patents | 93 |
| First publication | May 10, 2018 |
| Latest publication | Mar 10, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12570961-B2 · Mar 10, 2026 · US
US-12570959-B2 · Mar 10, 2026 · US
US-2026061052-A1 · Mar 5, 2026 · US
US-12558375-B2 · Feb 24, 2026 · US
US-12553029-B2 · Feb 17, 2026 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12570961-B2 · Mar 10, 2026 · US
US-12570959-B2 · Mar 10, 2026 · US
US-2026061052-A1 · Mar 5, 2026 · US
US-12558375-B2 · Feb 24, 2026 · US
US-12553029-B2 · Feb 17, 2026 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 296 |
| Chemistry & Metallurgy | 295 |
| Physics | 74 |
| Operations & Transport | 2 |
| Cross-Sectional Technologies | 2 |
| Mechanical Engineering | 1 |
Answers are generated from the same data shown on this page.